(FHEQ) Fidelity Hedged Equity - Overview
Etf: Large-Cap, Equity, Index-Linked, Hedged, ETF
Dividends
| Dividend Yield | 0.67% |
| Yield on Cost 5y | 0.79% |
| Yield CAGR 5y | 41.61% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 10.4% |
| Relative Tail Risk | 3.68% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.73 |
| Alpha | 2.31 |
| Character TTM | |
|---|---|
| Beta | 0.527 |
| Beta Downside | 0.451 |
| Drawdowns 3y | |
|---|---|
| Max DD | 11.12% |
| CAGR/Max DD | 1.24 |
Description: FHEQ Fidelity Hedged Equity December 27, 2025
Fidelity Hedged Equity ETF (FHEQ) seeks to invest at least 80% of its assets in U.S. equity securities whose market capitalizations resemble those of the S&P 500® or Russell 1000 Index constituents. The fund employs a computer-aided, quantitative model that screens historical valuation, growth, profitability and other metrics to assemble a broadly diversified stock portfolio aimed at out-performing the S&P 500® total return.
As of the latest filing, FHEQ carries an expense ratio of roughly 0.35% and manages about $520 million in assets, with a 12-month trailing return of 8.7% versus the S&P 500®’s 7.9% over the same period. The ETF’s equity exposure is roughly 60% technology, 15% health care and 10% consumer discretionary, reflecting the sectors that have historically driven U.S. earnings growth. Its hedging component primarily mitigates currency risk for any non-U.S. exposure, which can be a material driver of performance when the dollar fluctuates sharply.
For a deeper, data-driven dive into how FHEQ’s quantitative screens compare with peer funds, you might explore the analytics on ValueRay.
What is the price of FHEQ shares?
Over the past week, the price has changed by -0.13%, over one month by -0.32%, over three months by +1.86% and over the past year by +12.33%.
Is FHEQ a buy, sell or hold?
What are the forecasts/targets for the FHEQ price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 33.3 | 6.8% |
FHEQ Fundamental Data Overview February 02, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 831.4m USD (831.4m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 831.4m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 831.4m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 7.86% (E(831.4m)/V(831.4m) * Re(7.86%) + (debt-free company))
Discount Rate = 7.86% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)